Nivolumab plus ipilimumab in melanoma patients with asymptomatic brain metastases: 7-year outcomes and quality of life from the multicenter phase III NIBIT-M2 trial-Reference-Cited by-同舟云学术

Nivolumab plus ipilimumab in melanoma patients with asymptomatic brain metastases: 7-year outcomes and quality of life from the multicenter phase III NIBIT-M2 trial

Published:2024-03 Issue: Volume:199 Page:113531
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Di Giacomo Anna Maria,Chiarion-Sileni Vanna,Del Vecchio Michele,Ferrucci Pier Francesco,Guida Michele,Quaglino Pietro,Guidoboni Massimo,Marchetti Paolo,Simonetti Elena,Santangelo Federica,Amato Giovanni,Covre Alessia,Camerini Roberto,Valente Monica,Mandalà Mario,Giannarelli Diana,Calabrò Luana,Maio Michele

Publisher

Elsevier BV

Reference12 articles.

1. Immunotherapy of brain metastases: breaking a "dogma;Di Giacomo;J Exp Clin Cancer Res,2019

2. Nivolumab plus ipilimumab in melanoma brain metastases;Di Giacomo;Lancet Oncol,2022

3. Immunotherapy for brain metastases and primary brain tumors;Di Giacomo;Eur J Cancer,2023

4. Ipilimumab and fotemustine in patients with advanced melanoma (NIBIT-M1): an open-label, single-arm phase 2 trial;Di Giacomo;Lancet Oncol,2012

5. Three-year follow-up of advanced melanoma patients who received ipilimumab plus fotemustine in the Italian Network for Tumor Biotherapy (NIBIT)-M1 phase II study;Di Giacomo;Ann Oncol,2015

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Melanoma Brain Metastasis;Hematology/Oncology Clinics of North America;2024-10

2. Achievements of international rare cancers networks and consortia in the neuro-oncology field;Current Opinion in Oncology;2024-08-29

3. Real-World Comparison of Health-Related Quality of Life Associated with Use of Immune-Checkpoint Inhibitors in Oncology Patients;Journal of Clinical Medicine;2024-08-20

4. First-Line Nivolumab Plus Relatlimab Versus Nivolumab Plus Ipilimumab in Advanced Melanoma: An Indirect Treatment Comparison Using RELATIVITY-047 and CheckMate 067 Trial Data;Journal of Clinical Oncology;2024-08-13

5. Melanoma Management: Exploring Staging, Prognosis, and Treatment Innovations;International Journal of Molecular Sciences;2024-05-26